As Allergan, an AbbVie Company, we’ve been creating innovative products and services for our patients for over 70 years and we continue to push the boundaries of what’s possible in eye care each and every day. When Gavin S. Herbert founded the first antihistamine eye drop, he ignited an enduring spirit of innovation and a passion for finding solutions that preserve vision. From the very early days, Herbert understood the importance of working with front-line eye care professionals to identify the products that result in the best outcomes for patients. Since then our eye care products have helped manage and preserve the vision of millions of people worldwide.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
ImprimisRx® is pioneering a new commercial pathway in the pharmaceutical industry, using compounding pharmacies for the formulation and distribution of high quality, proprietary, compounded formulations. We are patient focused and we do this by partnering with healthcare providers to ensure high quality medications at affordable prices for your patients. Imprimis’ pharmacies is able to ship to all 50 states.
At ImprimisRx we are committed to earning your trust every day by providing quality products and exceptional service! We back this commitment up with a 100% money back guarantee on every order
placed with our 503B FDA Registered Outsourcing Facility and 503A Patient Specific Pharmacy. Download PharmaPack® info here.
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Glaukos was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure that revolutionized the treatment and management of glaucoma. In 2012, they launched the first MIGS device, the iStent®, in the United States, followed by the next-generation iStent inject® device in September 2018 and iStentinject® W in September 2020.
Since 1985, we’ve made it our mission to invest in the healing power of ophthalmic laser technology and help to transform the sight and the lives of people across the globe.
Today, more than 35,000 Ellex ophthalmic laser and ultrasound systems are in use in over 100 countries around the world, achieving ophthalmic outcomes once never thought possible — safely, effectively, accurately and consistently.
Since its inception in 1984, FCI has become a world leader in the development of ophthalmic surgical devices. Starting in France, FCI leveraged relationships with leading surgeons to distribute internationally. In 1996 FCI expanded to the US with the creation of FCI Ophthalmics.
The products manufactured by FCI include a full range of cataract surgery devices, lacrimal stents and tubes, orbital implants, retinal detachment devices, ptosis repair devices, knives and sutures, and dry eye products. FCI works closely with ophthalmic surgeons worldwide to continually develop state-of-the-art ophthalmic surgical devices and other eye care products. FCI is proud to help physicians improve the quality of their patients’ lives through better vision. With advanced materials and innovative research, FCI responds to the ever-changing needs of eye care professionals.
As we build a growing pipeline and explore all potential uses for our medicines, we strive to make a powerful difference for our patients, their caregivers and physicians every day. Our drive to deliver breakthrough therapies comes from our deep understanding of the patient journey. These patients’ courage inspires us – and drives us to listen, collaborate and build communities. That’s why, at our core, we believe science and compassion must work together to transform lives.
Eyesight is undervalued and under treated—and we believe that it is our We marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift. Nearly 1.3 billion people around the world face impaired vision, and 80% of those cases are preventable with early diagnosis and vision treatment. We are committed to changing these statistics.
Oyster Point Pharma is a biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies to treat ophthalmic disease. They continuously strive to advance breakthrough science and deliver therapies seeking to address the unmet needs of patients and eye care professionals. Driven by data and motivated by passion, Oyster Point is powered by a team with diverse talents and more than 100 years of combined experience in ophthalmology.
Bio-Tissue, a subsidiary of TissueTech, is the pioneer and leader in regenerative medicine for ocular surface disease and injury, as well as ocular hygiene solutions for eye care professionals. Established in 1997, Bio-Tissue serves an unmet need for better surgical and therapeutic alternatives for helping eye care professionals manage ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis (CCh) also known as mechanical dry eye, pterygium and severe dry eye.
Eye care professionals understand that good medicine is based on good science. Bio-Tissue prides itself on developing products that meet the highest clinical standards, are based on quality research and scientific data, and provide innovative solutions for the management of a range of ocular surface and lid margin diseases. Bio-Tissue adheres to the FDA tissue and medical device guidelines.
At RVL Pharmaceuticals, we strive to improve patients’ lives by providing innovative, clinically proven products that can help reshape how we approach ocular health.
Our current focus is delivering new products, such as Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%, to address a significant unmet need among patients.
Sight is one of the most important senses. We at iCare work passionately to protect it. We believe that eye care must be effortless, accurate, and reliable. With our innovative, high-quality solutions we want to help eye care professionals to do their job faster, easier, and more precisely.
iCare provides eye doctors with the latest solutions for comprehensive screening, diagnostics and monitoring of glaucoma, diabetic retinopathy, and macular degeneration (AMD). Our product line includes automated TrueColor imaging devices, perimeters and handheld rebound tonometers.
The Hydrus Microstent is a revolutionary therapy used during cataract surgery to help manage your glaucoma. It has been proven in global clinical trials to lower eye pressure, which resulted in a reduction of glaucoma medicine and, in some patients, eliminated the need for medication.
As a highly specialized division for ophthalmic specialists, Sun Ophthalmics is able to anticipate needs from the professional and patient eye care community and quickly respond. With our experience and commitment to a working partnership, you and your staff can get more of what you want and need from our dedicated team. We look forward to meeting your passion with our experience and support every step of the way. stablished in 2015, Sun Ophthalmics is backed by Sun Pharma, a multinational pharmaceutical company.
Our journey began in Nigeria over 30 years ago, when a young professor inundated with patients suffering from onchocerciasis dedicated himself to alleviating ophthalmic ailments. After moving to California a few years later, Dr. A. Mateen Ahmed founded New World Medical and introduced the Ahmed® Glaucoma Valve to the world.
New World Medical was founded to benefit humanity. Our firm works to live up to this lofty goal by creating and manufacturing cutting-edge glaucoma surgical devices intended to alleviate the suffering of glaucoma patients globally. Dedicated surgical sales consultants provide support for New World Medical’s flagship products, which include the Ahmed® Glaucoma Valve, Ahmed ClearPath®, Kahook Dual Blade®, and KDB GLIDE® throughout the United States. Internationally, the company utilizes an exclusive distribution network to reach patients in need.
OMIC is the largest insurer of ophthalmologists in the United States. Formed in 1987 by a group of visionary eye doctors, our specialty-specific program is unique in our industry. Our mission is to serve the needs of members of the American Academy of Ophthalmology by providing high quality medical liability insurance products and services. OMIC strives to be a leader in the medical liability community and to promote quality ophthalmic care and patient safety.
The Center for Ocular Prosthetics has been the Portland area’s leading maker of ocular prosthetics for more than 40 years.
We help everyone from young babies to seniors, and even dogs! Our patients are courageous survivors of accidents and illnesses. We take the time to get to know you and personalize your custom, one-of-a-kind prosthetic eye, ensuring perfect fit, comfort, and a natural appearance.
Ocularist Christina King is a board-certified ocularist who creates beautiful, lifelike prosthetic eyes, personalized just for you.
The Oregon Commission for the Blind was established in 1937 as a state agency to provide services to Oregon’s citizens who experience vision loss and need specialized training and support to live full and productive lives. The agency receives policy direction and oversight from a seven member Commission representing consumer organizations, education, ophthalmology/optometry, business and individual citizens. We help Oregonians who are blind get and keep jobs that allow them to support themselves and their families and we support Oregon businesses in hiring and retaining qualified job seekers who are blind.